Abstract
2325P Selinexor (XPO1 inhibitor) in combination with tepotinib (MET inhibitor) potentially inhibits SHOC2 and KRAS G12C in KRAS G12C mutant non-small cell lung cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have